Literature DB >> 9437200

Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects.

M Tilly-Kiesi1, A H Lichtenstein, J Joven, E Vilella, M C Cheung, W V Carrasco, J M Ordovas, G Dolnikowski, E J Schaefer.   

Abstract

The behavior of apolipoprotein (apo) A-I in lipoprotein (Lp) AI and LpAI:AII was studied in 11 postmenopausal females and 11 males matched for plasma triglyceride and total cholesterol levels. Subjects consumed a baseline diet [35% fat (14% saturated, 15% monounsaturated, and 7% polyunsaturated), 15% protein, 49% carbohydrate, and 147 mg cholesterol/1000 kcal] for 6 weeks before the start of the kinetic study. At the end of the diet period, using a primed-constant infusion of [5,5,5-2H3]leucine, residence times (RT) and secretion rates (SR) of apoA-I were determined in 2 subpopulations of high-density lipoprotein (HDL) particles, LpAI and LpAI:AII. Plasma total cholesterol, low-density lipoprotein cholesterol, and triglyceride concentrations were similar in males and females. The mean plasma HDL cholesterol concentration in males (1.14 +/- 0.23 mmol/L; mean +/- SD) was lower than in females (1.42 +/- 0.18 mmol/L; P =. 0034). Similarly, the mean plasma concentration of apoA-I in males (130 +/- 21 mg/dL) was lower than that in females (150 +/- 19 mg/dL; P = .0421). The RT of apoA-I in either LpAI or LpAI:AII was similar between men and women. Despite the higher plasma apo A-I levels in female compared with male subjects, total apoA-I and apoA-I in LpAI and LpAI:AII pool sizes were similar between the two groups, attributable to the lower body weight of the female subjects. The mean SR of total apoA-I in males (8.5 +/- 2.7 mg.kg-1.d-1) was 22% lower than in females (10.9 +/- 2.3 mg.kg-1.d-1; P = .0389). The SR of both apoA-I in LpAI and LpAI:AII was lower in males than females, although the differences did not reach statistical significance. These data suggest that the difference observed in HDL cholesterol concentration between males and females is attributable to SR of apoA-I and not the catabolic rate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9437200     DOI: 10.1161/01.atv.17.12.3513

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice.

Authors:  C Alicia Traughber; Emmanuel Opoku; Gregory Brubaker; Jennifer Major; Hanxu Lu; Shuhui Wang Lorkowski; Chase Neumann; Aimalie Hardaway; Yoon-Mi Chung; Kailash Gulshan; Nima Sharifi; J Mark Brown; Jonathan D Smith
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

Review 2.  Gender differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease.

Authors:  Robert H Knopp; Pathmaja Paramsothy; Barbara M Retzlaff; Brian Fish; Carolyn Walden; Alice Dowdy; Christine Tsunehara; Keiko Aikawa; Marian C Cheung
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

3.  Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease.

Authors:  Robert H Knopp; Pathmaja Paramsothy; Barbara M Retzlaff; Brian Fish; Carolyn Walden; Alice Dowdy; Christine Tsunehara; Keiko Aikawa; Marian C Cheung
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

4.  Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women.

Authors:  Francine K Welty; Alice H Lichtenstein; Stefania Lamon-Fava; Ernst J Schaefer; Julian B Marsh
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

5.  Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).

Authors:  Marian C Cheung; Shalamar D Sibley; Jerry P Palmer; John F Oram; John D Brunzell
Journal:  J Lipid Res       Date:  2003-06-01       Impact factor: 5.922

6.  Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.

Authors:  Esther M M Ooi; Gerald F Watts; Paul J Nestel; Dmitri Sviridov; Anh Hoang; P Hugh R Barrett
Journal:  J Clin Endocrinol Metab       Date:  2007-11-20       Impact factor: 5.958

7.  Moderate amounts of fructose- or glucose-sweetened beverages do not differentially alter metabolic health in male and female adolescents.

Authors:  Timothy D Heden; Ying Liu; Young-Min Park; Lauryn M Nyhoff; Nathan C Winn; Jill A Kanaley
Journal:  Am J Clin Nutr       Date:  2014-07-16       Impact factor: 7.045

8.  Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Authors:  F Magkos; B S Mohammed; B Mittendorfer
Journal:  Int J Obes (Lond)       Date:  2008-09-09       Impact factor: 5.095

9.  Distinct metabolic effects following short-term exposure of different high-fat diets in male and female mice.

Authors:  Shiva P D Senthil Kumar; Minqian Shen; Elizabeth G Spicer; Ashley J Goudjo-Ako; Justin D Stumph; Jing Zhang; Haifei Shi
Journal:  Endocr J       Date:  2014-03-20       Impact factor: 2.349

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.